BioCentury | Jan 18, 2016
Company News

Cour Pharmaceutical, Takeda deal

...cooperation with Northwestern University (Evanston, Ill.). Takeda will have an exclusive option to globally license TIMP/Gliadin...
...Phase IIa trial and an option to collaborate on up to three additional TIMP compounds. TIMP/Gliadin...
Items per page:
1 - 1 of 1